Second Circuit Vacates Pharmaceutical Misbranding Conviction on Free Speech Grounds

 

Topics:  Caronia, Commercial Speech, FDCA, First Amendment, Free Speech, Marketing, Misbranding, Off-Label Promotion, Off-Label Use, Pharmaceutical

Published In: Communications & Media Updates, Constitutional Law Updates, Criminal Law Updates, Government Contracting Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Holland & Knight LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »